JP TSE 4588 Pharmaceutical

Oncolys BioPharma Inc.

オンコリスバイオファーマ株式会社

Fiscal year ends
Dec
Latest results
FY ending Dec 2025
Employees
38
Revenue
¥28.5M
≈ $181K
Net income
−¥2.1B
≈ −$13.0M
Income taxes paid
¥4.0M
≈ $26K
Total assets
¥4.6B
≈ $28.8M
Equity ratio
87.8%
 

Ranked #3,852 among listed Japanese companies by corporate taxes paid.

US dollar amounts use ¥158.0 per dollar.

Annual results

Fiscal yearRevenueNet incomeTax expenseTaxes paidTotal assetsNet assetsEquity ratioSource
Dec 2025¥28.5M−¥2.1B ¥4.0M¥4.0M ¥4.6B¥4.0B87.8% EDINET
Dec 2024¥31.4M−¥1.7B ¥3.8M¥2.9M ¥3.2B¥2.8B86.0% EDINET
Dec 2023¥63.0M−¥1.9B —— ¥2.0B¥1.5B72.2% EDINET
Dec 2022¥976M−¥1.1B —— ¥2.7B¥2.2B81.5% EDINET
Dec 2021¥642M−¥1.6B —— ¥4.3B¥3.6B83.7% EDINET

From annual securities reports filed with the Financial Services Agency's EDINET. 日本語のページ(同業比較・役員)

Compare with the world's largest companies

See where Japanese companies stand in the world rankings by revenue, profit and taxes paid.

World rankings